The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Cell And Gene Therapy Contract Research Organization Market During 2026–2030?
The market size for cell and gene therapy contract research organizations has experienced rapid expansion recently. This market is projected to expand from $6.92 billion in 2025 to $7.76 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.1%. Historically, this growth has been driven by factors such as a rising number of early-stage cell and gene therapy programs, constrained internal development capacities, an increase in rare disease research pipelines, growing regulatory challenges in advanced therapies, and a greater dependency on external research expertise.
The cell and gene therapy contract research organization market size is poised for significant expansion in the upcoming years. It is projected to reach $12.36 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This projected growth can be attributed to heightened clinical trial activity in gene therapies, the expansion of personalized medicine development, increased investments in oncology and genetic disorder research, a growing need for accelerated development timelines, and enhanced collaboration between biotechnology firms and CROs. Prominent trends anticipated during this period include a rise in outsourcing of cell and gene therapy research, an escalating demand for integrated preclinical and clinical services, a stronger focus on regulatory and compliance expertise, the expansion of vector development and manufacturing support, and improved utilization of data-driven trial management.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33057&type=smp
What Drivers Are Expected To Influence The Cell And Gene Therapy Contract Research Organization Market During The Forecast Period?
An increasing emphasis on personalized medicine and targeted therapeutics is anticipated to drive expansion in the cell and gene therapy contract research organization (CRO) market going forward. These approaches entail crafting treatments specifically for an individual’s unique genetic, molecular, or cellular profile, aiming to enhance effectiveness and minimize unwanted side effects. The heightened attention on personalized medicine stems from regulators and healthcare systems giving precedence to precision-based therapies for tackling intricate diseases and attaining better clinical outcomes. Cell and gene therapy contract research organizations (CROs) play a crucial role in advancing personalized medicine by offering expert preclinical, clinical, and regulatory assistance essential for the creation, evaluation, and validation of sophisticated gene- and cell-based therapeutic products. As an illustration, in April 2025, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the Food and Drug Administration (FDA) sanctioned 18 personalized medicines in 2024, constituting approximately 38% of all newly authorized therapeutic molecular entities. Consequently, the growing concentration on personalized medicine and targeted therapeutics is fueling the expansion of the cell and gene therapy contract research organization (CRO) market.
How Are The Various Segments Of The Cell And Gene Therapy Contract Research Organization Market Categorized?
The cell and gene therapy contract research organization market covered in this report is segmented –
1) By Type: Preclinical Contract Research Organization; Clinical Stage Contract Research Organization; Other Types
2) By Service: Project And Clinical Trial Management; Regulatory Strategy; Data Management And Medical Writing; Clinical Monitoring; Quality Management And Good Manufacturing Practice Compliance; Biostatistics And Safety Monitoring; Patient And Site Recruitment; Technology Transfer; Other Services
3) By Indication: Oncology; Central Nervous System Disorders; Infectious Diseases; Immunological Disorders; Cardiovascular Diseases; Respiratory Diseases; Diabetes; Ophthalmology; Pain Management; Other Indications
4) By Modality: Cell-Based Therapies; Gene Therapies; Gene-Modified Cell Therapies
5) By Application: Hospital; Research Institute; Other Applications
Subsegments:
1) By Preclinical Contract Research Organization: In Vitro Testing Services; In Vivo Animal Model Services; Toxicology And Safety Assessment; Other Preclinical Services
2) By Clinical Stage Contract Research Organization: Phase I Clinical Trial Services; Phase II Clinical Trial Services; Phase III Clinical Trial Services; Other Clinical Stage Services
3) By Other Types: Regulatory Consulting Services; Process Development Services; Manufacturing Support Services; Other Support Services
What Trends Are Affecting The Expansion Of The Cell And Gene Therapy Contract Research Organization Market?
Key players within the cell and gene therapy contract research organization (CRO) market are prioritizing the creation of innovative solutions, including expanded laboratory and analytical services, to boost therapy development efficiency, ensure regulatory compliance, and refine research precision. This is achieved by offering cutting-edge facilities, specialized equipment, and integrated capabilities for cell and gene therapy testing. Expanded laboratory and analytical services represent contract research organization (CRO) provisions that increase operational capacity, enable the execution of complex assays, and support sponsors through the complete development cycle of advanced cell and gene therapies. For example, in August 2025, Labcorp Holdings Inc., a US-based healthcare company, enlarged its cell and gene therapy laboratory in madison, wisconsin, thereby improving its proficiency in cell characterization, vector analytics, and testing that meets regulatory requirements. This enhanced facility delivers specialized infrastructure for intricate cell and gene therapy workflows, facilitates high-throughput sample processing, and integrates advanced analytical platforms, establishing itself as a holistic solution for accelerating cell and gene therapy research and development.
Which Major Firms Influence Developments In The Cell And Gene Therapy Contract Research Organization Market?
Major companies operating in the cell and gene therapy contract research organization market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Fortrea Holdings Inc., CMIC Co. Ltd., Medpace Holdings Inc., PharmaLex GmbH, Premier Research International LLC, Worldwide Clinical Trials Inc., Novotech (Australia) Pty Ltd., Precision for Medicine Inc., Syngene International Limited, Allucent Inc., TFS HealthScience AB, QPS Holdings LLC, Altasciences Company Inc., Veristat LLC, Linical Co. Ltd., Aixial Group, ProRelix Research LLC
Read the full cell and gene therapy contract research organization market report here:
Which Region Currently Holds The Largest Share Of The Cell And Gene Therapy Contract Research Organization Market?
North America was the largest region in the cell and gene therapy contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cell And Gene Therapy Contract Research Organization Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33057&type=smp
Browse Through More Reports Similar to the Global Cell And Gene Therapy Contract Research Organization Market 2026, By The Business Research Company
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Market Report 2026
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model